Skip to content

Aurobindo Pharma US FDA inspection ends with one observation at AuroPeptides facility

Shares of Aurobindo Pharma Ltd ended at ₹1,619.95, up by ₹13.55, or 0.84%, on the BSE.​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *